Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-20-032970

Chief Medical Officer acquired 5,515 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Detke Michael J. · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-05-27 Exercise or conversion : show line 1 in the form +5,515 $6.91 $38,109 28,261 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-05-27 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −5,515 104,091 D
Loading xslF345X03/doc4.xml…